BSEBoard Meeting3d ago · 6 Nov 2026, 07:43 pm
Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, 06th November, 2026, at the Registered Office of the Company, has inter alia considered and approved the following businesses: 1. Approved the Unaudited Standalone and Consolidated ....
Vivanza Biosciences Ltd · 530057
✦ AI SummaryResults
The Board of Directors of Vivanza Biosciences Ltd has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended on 30th September, 2026, along with the Limited Review Report.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited Held On 06.11.2026